ONC

BEONE MEDICINES LTD

ONC·07725L102·US·ADR·Healthcare - Biotechnology-Activist

ONC (BEONE MEDICINES LTD) is held by 147 institutional investors as of Q1 2026. Largest holders: BAKER BROS. ADVISORS LP ($2.6B), PRIMECAP MANAGEMENT CO/CA/ ($1.5B), Capital International Investors ($1.2B). Net institutional sentiment: Mixed.

147
Holders
(14 Elite)
$9.9B
Total Value
57% (152)
Consensus
86 buying - 66 selling
13F: Insider & Congress:
ONC

Smart Money Verdict

View all
Held by 147 funds
14 elite

Who's Trading

InsiderLHLee Chan HenrySell $201KJul 8, 2026
InsiderWXWu XiaobinSell $357KJun 23, 2026
InsiderWLWang LaiSell $296KJun 23, 2026
InsiderLHLee Chan HenrySell $157KJun 16, 2026
InsiderWLWang LaiSell $310KJun 16, 2026
ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP8.0%Jun 15, 2026
InsiderWLWang LaiSell $197KJun 11, 2026
InsiderLHLee Chan HenrySell $110KJun 11, 2026
InsiderRARosenberg AaronSell $163KJun 11, 2026
ActivistCapital International InvestorsCapital International Investors4.2%May 14, 2026

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
8.8M$2.6B15.0%+100.30%
0
Decreased
5M(-0.1%)$1.5B1.2%+45.35%
0
Decreased
4.2M(-18.7%)$1.2B0.3%+66.38%
0
Decreased
3.7M(-7.5%)$1.1B0.1%+26.47%
0
New
1.6M$481.9M0.1%+0.56%
43
Unchanged
1M$307.2M18.4%+122.87%
0
Increased
1M(+93.5%)$306.6M0.0%-0.03%
49
Decreased
862,643(-6.2%)$256.2M0.8%+84.67%
0
Decreased
657,501(-2.8%)$195.3M0.0%+38.28%
0
Decreased
539,769(-60.7%)$160.3M0.0%+22.11%
0
Increased
464,472(+6.1%)$137.9M0.0%+24.92%
32
Increased
415,330(+173.1%)$123.3M0.0%+6.98%
49
Increased
405,273(+7.0%)$120.4M0.0%+23.14%
32
Increased
349,651(+14.9%)$103.8M0.2%+49.77%
41
Decreased
302,243(-1.8%)$89.8M0.7%+85.97%
0
Increased
259,731(+31.7%)$77.1M0.4%+8.81%
45
Decreased
241,922(-2.6%)$71.8M0.1%+13.41%
0
Increased
241,426(+91.9%)$71.7M0.1%+21.18%
47
Increased
204,846(+551.3%)$60.8M0.0%+2.99%
48
Increased
201,641(+113.2%)$59.9M0.0%-0.17%
48

Showing 1-20 of 161

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used